The effects of aspirin and paracetamol on the aggregation of equine blood platelets.

This research focuses on examining the effects of aspirin and paracetamol on the clotting process, specifically the aggregation (clumping together) of platelets, in horse blood. The study concludes that the generation of thromboxane A2, a compound involved in blood clotting, plays a minor role in equine platelet aggregation, and it does not significantly influence irreversible aggregation.

Study Design and Procedures

• The researchers analyze the reactions of blood platelets hosted in a specific type of plasma (citrated platelet-rich plasma) under the influence of various blood-clotting agents. These include arachidonic acid, adenosine 5′-diphosphate, platelet-activating factor, collagen, and U44069, a synthetic substance modeled after a naturally occurring prostaglandin.
• The procedure encompasses the measurement of platelet aggregation through turbidimetric aggregometry, which involves analyzing light transmission through platelet suspension. This process measures the rate of light blockage due to platelet aggregation.
• The platelets are then pretreated with either aspirin or paracetamol at specific concentrations and their response to the said clotting agents is analyzed.

Results of the Research

• Both aspirin and paracetamol drastically reduce the shape change of platelets and their aggregation when exposed to arachidonic acid.
• The rate of aggregation in response to collagen is likewise affected, albeit without any separate impact on the shape change.
• The two drugs did not significantly alter the aggregation influenced by the other tested agonists.
• In no situation were the drugs found to transform irreversible aggregation into reversible aggregation.

Conclusions of the Research

• Thromboxane A2, a specific type of prostaglandin implicated in blood clotting, contributes minimally to platelet aggregation in horse blood.
• The research further concludes that thromboxane A2 does not considerably mediate irreversible platelet aggregation, thus suggesting that aspirin and paracetamol’s effectiveness in preventing clotting may not be due to their influence on thromboxane A2 levels.